The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-08-22
DOI
10.1111/liv.14220
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transforming Growth Factor-β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma
- (2018) Christine Haider et al. HEPATOLOGY
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
- (2018) Danielle Benedict Sacdalan et al. OncoTargets and Therapy
- Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma
- (2018) Yusheng Cheng et al. Cell Death & Disease
- Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma
- (2018) Bernhard Scheiner et al. Liver Cancer
- Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta-analysis
- (2018) Qiaoyun Tan et al. Thoracic Cancer
- The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy
- (2018) Mehmet A. Bilen et al. CANCER
- Challenges and opportunities in the clinical development of immune checkpoint inhibitors for hepatocellular carcinoma
- (2018) Michael J Flynn et al. HEPATOLOGY
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
- (2017) Stefan Diem et al. LUNG CANCER
- Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
- (2017) Matthias Pinter et al. Science Translational Medicine
- Neutrophil to lymphocyte ratio predicts disease progression following intra-arterial therapy of hepatocellular carcinoma
- (2017) Matthew D. Taussig et al. HPB
- Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
- (2017) A. Rebonato et al. Gastroenterology Research and Practice
- Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib
- (2017) Jessica Howell et al. Oncotarget
- Use of inhibitors of the renin–angiotensin system is associated with longer survival in patients with hepatocellular carcinoma
- (2017) Matthias Pinter et al. United European Gastroenterology Journal
- Platelets contribute to growth and metastasis in hepatocellular carcinoma
- (2016) Chhagan Bihari et al. APMIS
- Angiotensin II Enhances Proliferation and Inflammation through AT1/PKC/NF-κB Signaling Pathway in Hepatocellular Carcinoma Cells
- (2016) Yuanyuan Ji et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Activated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding
- (2016) Rongfeng Zhang et al. Oncotarget
- Novel TGF-β inhibitors ready for prime time in onco-immunology
- (2016) Armand de Gramont et al. OncoImmunology
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification
- (2015) David J. Pinato et al. Clinical Gastroenterology and Hepatology
- Serotonin and Cancer: What Is the Link?
- (2015) D. Sarrouilhe et al. CURRENT MOLECULAR MEDICINE
- CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice
- (2015) Yunching Chen et al. HEPATOLOGY
- Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
- (2015) Stefano Ugel et al. JOURNAL OF CLINICAL INVESTIGATION
- CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma
- (2015) Li Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients
- (2015) Antonio Facciorusso et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Increased autophagy sustains the survival and pro-tumourigenic effects of neutrophils in human hepatocellular carcinoma
- (2015) Xue-Feng Li et al. JOURNAL OF HEPATOLOGY
- Transarterial chemoembolization: Modalities, indication, and patient selection
- (2015) Wolfgang Sieghart et al. JOURNAL OF HEPATOLOGY
- Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
- (2015) Xavier Adhoute et al. JOURNAL OF HEPATOLOGY
- Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study
- (2014) D. J. Pinato et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
- (2014) A. M. Di Giacomo et al. ANNALS OF ONCOLOGY
- Preoperative Aspartate Aminotransferase to Platelet Ratio is an Independent Prognostic Factor for Hepatitis B-Induced Hepatocellular Carcinoma After Hepatic Resection
- (2014) Shun-Li Shen et al. ANNALS OF SURGICAL ONCOLOGY
- The Blood Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib
- (2014) You-Bing Zheng et al. Asian Pacific Journal of Cancer Prevention
- Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro
- (2014) Brian I Carr et al. BMC CANCER
- Antagonism of Sorafenib and Regorafenib actions by platelet factors in hepatocellular carcinoma cell lines
- (2014) Rosalba D’Alessandro et al. BMC CANCER
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Cytochrome P450-Mediated Biotransformation of Sorafenib and Its N-Oxide Metabolite: Implications for Cell Viability and Human Toxicity
- (2014) Tina B. Gillani et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Molecular Pathways: Aspirin and Wnt Signaling--A Molecularly Targeted Approach to Cancer Prevention and Treatment
- (2014) M. K. Gala et al. CLINICAL CANCER RESEARCH
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
- (2014) B. Hu et al. CLINICAL CANCER RESEARCH
- Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis
- (2014) Ruipeng Song et al. HEPATOLOGY
- Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer
- (2014) Jordi Rodón et al. INVESTIGATIONAL NEW DRUGS
- Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation
- (2014) Antonio Facciorusso et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma
- (2014) Florian Hucke et al. JOURNAL OF HEPATOLOGY
- Cancer-related inflammation and treatment effectiveness
- (2014) Connie I Diakos et al. LANCET ONCOLOGY
- Reactive Oxygen Species Prevent Imiquimod-Induced Psoriatic Dermatitis through Enhancing Regulatory T Cell Function
- (2014) Hyung-Ran Kim et al. PLoS One
- Mutations of C-Reactive Protein (CRP) -286 SNP, APC and p53 in Colorectal Cancer: Implication for a CRP-Wnt Crosstalk
- (2014) Hai-Xiang Su et al. PLoS One
- Platelet-Related Phenotypic Patterns in Hepatocellular Carcinoma Patients
- (2014) Brian I. Carr et al. SEMINARS IN ONCOLOGY
- Platelets Promote Liver Immunopathology Contributing to Hepatitis B Virus–Mediated Hepatocarcinogenesis
- (2014) Giovanni Sitia SEMINARS IN ONCOLOGY
- Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma
- (2014) Junichi Shindoh et al. TRANSPLANT INTERNATIONAL
- Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis
- (2013) Derick Okwan-Duodu et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer
- (2013) L. Kadalayil et al. ANNALS OF ONCOLOGY
- Preoperative Neutrophil-to-Lymphocyte Ratio Is a Predictor of Survival After Hepatectomy for Hepatocellular Carcinoma
- (2013) Yohei Mano et al. ANNALS OF SURGERY
- Oxidative Stress in Malignant Melanoma Enhances Tumor Necrosis Factor-α Secretion of Tumor-Associated Macrophages That Promote Cancer Cell Invasion
- (2013) Xuzhu Lin et al. ANTIOXIDANTS & REDOX SIGNALING
- Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma
- (2013) S Kondo et al. BRITISH JOURNAL OF CANCER
- Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study
- (2013) Anna E. Prizment et al. CANCER CAUSES & CONTROL
- Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
- (2013) Fumitaka Arihara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
- (2013) Graeme J.K. Guthrie et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer
- (2013) Abigale Lade et al. CURRENT OPINION IN ONCOLOGY
- Thrombocytosis and Hepatocellular Carcinoma
- (2013) Brian I. Carr et al. DIGESTIVE DISEASES AND SCIENCES
- Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
- (2013) Virginia Hernandez–Gea et al. GASTROENTEROLOGY
- Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells
- (2013) Martin Franz Sprinzl et al. HEPATOLOGY
- Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice
- (2013) Yunching Chen et al. HEPATOLOGY
- Angiotensin II Drives the Production of Tumor-Promoting Macrophages
- (2013) Virna Cortez-Retamozo et al. IMMUNITY
- Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
- (2013) Mei-Ling Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Platelets in Tumor Progression: A Host Factor That Offers Multiple Potential Targets in the Treatment of Cancer
- (2013) Deva Sharma et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Advanced age influences the dynamic changes in circulating C-reactive protein following injury
- (2013) David J Pinato et al. JOURNAL OF CLINICAL PATHOLOGY
- Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma
- (2013) Tamar Kapanadze et al. JOURNAL OF HEPATOLOGY
- The ART-strategy: Sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE
- (2013) Florian Hucke et al. JOURNAL OF HEPATOLOGY
- The Systemic Inflammatory Response and Its Relationship to Pain and Other Symptoms in Advanced Cancer
- (2013) B. J. Laird et al. ONCOLOGIST
- Elevated Plasma Fibrinogen Levels Are Associated with a Poor Prognosis in Patients with Hepatocellular Carcinoma
- (2013) Akiyoshi Kinoshita et al. ONCOLOGY
- Postoperative Neutrophil-to-Lymphocyte Ratio Change Predicts Survival of Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
- (2013) Jiaqiang Dan et al. PLoS One
- Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2
- (2013) Satoshi Takagi et al. PLoS One
- Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions
- (2013) Andrew Burroughs et al. SEMINARS IN LIVER DISEASE
- Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma
- (2013) Ruihua Ma et al. Nature Communications
- Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma
- (2012) A Kinoshita et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma
- (2012) Roniel Cabrera et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
- (2012) Donald C. McMillan CANCER TREATMENT REVIEWS
- IκBKβ and NFκB1 , NSAID use and risk of colorectal cancer in the Colon Cancer Family Registry
- (2012) Brenna L. Seufert et al. CARCINOGENESIS
- The TGF-β Signaling Pathway as a Pharmacological Target in a Hepatocellular Carcinoma
- (2012) Antonio Mazzocca et al. CURRENT PHARMACEUTICAL DESIGN
- Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma
- (2012) Liping Chen et al. EUROPEAN JOURNAL OF CANCER
- Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma
- (2012) Shao-Lai Zhou et al. HEPATOLOGY
- Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma
- (2012) Wolfgang Sieghart et al. HEPATOLOGY
- Glasgow Prognostic Score as a useful prognostic factor after hepatectomy for hepatocellular carcinoma
- (2012) Kei Horino et al. International Journal of Clinical Oncology
- A novel and validated prognostic index in hepatocellular carcinoma: The inflammation based index (IBI)
- (2012) David J. Pinato et al. JOURNAL OF HEPATOLOGY
- Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
- (2012) Takashi Motomura et al. JOURNAL OF HEPATOLOGY
- Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
- (2012) Annemijn M Algra et al. LANCET ONCOLOGY
- Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
- (2012) G. Sitia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma
- (2012) David J. Pinato et al. Translational Research
- Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?
- (2012) François Martin et al. TRENDS IN MOLECULAR MEDICINE
- Molecular Pathogenesis of Hepatocellular Carcinoma
- (2011) Helena Cornellà et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
- (2011) Myriam Labelle et al. CANCER CELL
- Extrahepatic Cancer Suppresses Nuclear Receptor-Regulated Drug Metabolism
- (2011) M. Kacevska et al. CLINICAL CANCER RESEARCH
- Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy
- (2011) Wei-Yu Kao et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Immunotherapeutic modulation of the suppressive liver and tumor microenvironments
- (2011) Tim Chan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation
- (2011) Tsung-Ming Chen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cancer-related inflammation: Common themes and therapeutic opportunities
- (2011) Frances R. Balkwill et al. SEMINARS IN CANCER BIOLOGY
- Inhibiting TGF-β signaling in hepatocellular carcinoma
- (2010) Gianluigi Giannelli et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
- (2010) J.-L. Raoul et al. CANCER TREATMENT REVIEWS
- Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection
- (2010) Haijun Zhou et al. GUT
- Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma
- (2010) Hung-Hsu Hung et al. Hepatology International
- Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma
- (2010) Dong-Ming Kuang et al. JOURNAL OF HEPATOLOGY
- Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters
- (2009) Ke Hao et al. BMC CANCER
- Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
- (2009) C Alfaro et al. BRITISH JOURNAL OF CANCER
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions
- (2009) K. Wu et al. CANCER RESEARCH
- Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma
- (2009) Hitoshi Yoshiji et al. JOURNAL OF HEPATOLOGY
- Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients
- (2009) Jing-Ping Zhang et al. JOURNAL OF HEPATOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Recurrence of Hepatocellular Carcinoma
- (2008) Morris Sherman NEW ENGLAND JOURNAL OF MEDICINE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More